文献速递脑血管病

锂与卒中恢复:啮齿类卒中模型与人类数据的系统综述和Meta分析

Lithium and Stroke Recovery: A Systematic Review and Meta-Analysis of Stroke Models in Rodents and Human Data.
PubMed 文献 · Stroke · 2022-08-15

该研究系统检索2000年1月至2021年9月Medline、Embase和PsycINFO,纳入42项研究,包括36项啮齿类卒中模型和6项人类研究(其中4项可做Meta分析)。啮齿类模型显示锂治疗与更小的卒中体积、减少的细胞凋亡和改善的卒中后功能相关;人类证据稀疏且不确定,双相障碍成人中4项研究有2项显示锂暴露与较低卒中风险相关,两项小型试验显示卒中后锂的临床获益不明确。

要点

  • 啮齿类卒中模型中锂治疗与更小卒中体积、减少细胞凋亡和改善神经功能相关。
  • 双相障碍成人中4项研究有2项显示锂暴露与较低卒中风险相关。
  • 两项小型试验显示卒中后锂的临床获益不明确,人类证据稀疏且不确定。

核心结论

  • 啮齿类卒中模型显示锂治疗一致的生物学和功能获益证据,而人类证据仍稀疏且不确定。
  • 锂在卒中后恢复中的潜在作用尚待充分的人类研究验证。

研究设计与样本

  • 系统综述和Meta分析,遵循PRISMA指南,检索Medline、Embase和PsycINFO中2000年1月至2021年9月发表的临床前和临床研究。
  • 从1625项检索研究中纳入42项进入系统综述,包括36项使用卒中前或卒中后锂治疗的啮齿类卒中模型和6项人类样本研究,其中4项可做Meta分析。
  • 对观察性研究进行随机效应Meta分析。
  • 动物模型综述按卒中类型和结局分层,人类数据细分为观察性研究和干预性研究。

主要发现

  • 啮齿类接受锂治疗与更小的卒中体积、减少的细胞凋亡和改善的卒中后功能相关。
  • 在双相障碍成人中,4项研究有2项显示锂暴露与较低卒中风险相关。
  • 两项小型试验显示卒中后锂的临床获益不明确。

关键数值与推荐

  • 系统综述纳入42项研究,其中36项为啮齿类卒中模型,6项为人类研究,4项人类研究可做Meta分析。
  • 检索时间范围为2000年1月至2021年9月,检索数据库为Medline、Embase和PsycINFO。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 人类证据稀疏且不确定。
  • 锂在卒中后恢复中的潜在作用尚待充分的人类研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Lithium has neuroprotective effects in animal models of stroke, but benefits in humans remain uncertain. This article aims to systematically review the available evidence of the neuroprotective and regenerative effects of lithium in animal models of stroke, as well as in observational and trial stroke studies in humans. METHODS: This systematic review and meta-analysis was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We searched Medline, Embase, and PsycINFO for preclinical and clinical studies published between January 2000 and September 2021. A random-effects meta-analysis was conducted from observational studies. RESULTS: From 1625 retrieved studies, 42 were included in the systematic review. Of those, we identified 36 rodent models of stroke using preinsult or postinsult treatment with lithium, and 6 studies were conducted in human samples, of which 4 could be meta-analyzed. The review of animal models was stratified according to the type of stroke and outcomes. Human data were subdivided into observational and intervention studies. Treatment of rodents with lithium was associated with smaller stroke volumes, decreased apoptosis, and improved poststroke function. In humans, exposure to lithium was associated with a lower risk of stroke among adults with bipolar disorder in 2 of 4 studies. Two small trials showed equivocal clinical benefits of lithium poststroke. CONCLUSIONS: Animal models of stroke show consistent biological and functional evidence of benefits associated with lithium treatment, whereas human evidence remains sparse and inconclusive. The potential role of lithium in poststroke recovery is yet to be adequately tested in humans.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Almeida OP, Singulani MP, Ford AH, et al. Lithium and Stroke Recovery: A Systematic Review and Meta-Analysis of Stroke Models in Rodents and Human Data. Stroke. 2022. PMID: 35968702. doi:10.1161/STROKEAHA.122.039203

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。